THERMA BRIGHT INC (THRM.CA) Stock Price & Overview

TSX-V:THRM • CA8834262070

Current stock price

0.065 CAD
0 (0%)
Last:

The current stock price of THRM.CA is 0.065 CAD. Today THRM.CA is down by 0%. In the past month the price increased by 8.33%. In the past year, price decreased by -59.37%.

THRM.CA Key Statistics

52-Week Range0.045 - 0.2
Current THRM.CA stock price positioned within its 52-week range.
1-Month Range0.05 - 0.075
Current THRM.CA stock price positioned within its 1-month range.
Market Cap
3.693M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.07
Dividend Yield
N/A

THRM.CA Stock Performance

Today
0%
1 Week
N/A
1 Month
+8.33%
3 Months
-7.14%
Longer-term
6 Months -13.33%
1 Year -59.38%
2 Years -18.75%
3 Years -88.39%
5 Years -98.44%
10 Years N/A

THRM.CA Stock Chart

THERMA BRIGHT INC / THRM Daily stock chart

THRM.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to THRM.CA. When comparing the yearly performance of all stocks, THRM.CA is a bad performer in the overall market: 95.82% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

THRM.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to THRM.CA. THRM.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

THRM.CA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ1 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

THRM.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

THRM.CA Groups

Sector & Classification

Index Membership

THRM.CA Financial Highlights

Over the last trailing twelve months THRM.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -25.65% compared to the year before.


Income Statements
Revenue(TTM)75.20K
Net Income(TTM)-4.16M
Industry RankSector Rank
PM (TTM) N/A
ROA -1021.89%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%48.05%
Sales Q2Q%-100%
EPS 1Y (TTM)-25.65%
Revenue 1Y (TTM)98.94%

THRM.CA Ownership

Ownership
Inst OwnersN/A
Shares56.81M
Float52.55M
Ins Owners7.49%
Short Float %N/A
Short RatioN/A

About THRM.CA

Company Profile

THRM logo image Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.

Company Info

IPO: 2001-07-11

THERMA BRIGHT INC

345 Danforth Avenue

TORONTO ONTARIO M4M 3P1 CA

CEO: Rob Fia

Employees: 0

THRM Company Website

THRM Investor Relations

Phone: 18442746837

THERMA BRIGHT INC / THRM.CA FAQ

What does THRM do?

Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.


What is the stock price of THERMA BRIGHT INC today?

The current stock price of THRM.CA is 0.065 CAD.


What is the dividend status of THERMA BRIGHT INC?

THRM.CA does not pay a dividend.


How is the ChartMill rating for THERMA BRIGHT INC?

THRM.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the valuation of THERMA BRIGHT INC (THRM.CA) based on its PE ratio?

THERMA BRIGHT INC (THRM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).


What is the employee count for THRM stock?

THERMA BRIGHT INC (THRM.CA) currently has 0 employees.